 CAMBRIDGE, Mass. , Sept. 1, 2021 PRNewswire -- Akebia Therapeutics, Inc. Nasdaq: AKBA, a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. 